Langerhans cell histiocytosis associated with chronic myelomonocytic leukaemia both harbouring the same BRAF V600E mutation: efficacy of vemurafenib

被引：7
|
作者：
Konstantinou, M. P. [1 ]
Lucas, P. [1 ]
Uthurriague, C. [1 ]
Severino-Freire, M. [1 ]
Spenatto, N. [2 ]
Gaudin, C. [3 ]
Lamant, L. [4 ,5 ]
Tournier, E. [4 ,5 ]
Bulai-Livideanu, C. [1 ]
Meyer, N. [6 ,7 ]
Paul, C. [1 ]
机构：
[1] Paul Sabatier Univ, Univ Hosp Toulouse, Dermatol Dept, Toulouse, France
[2] Univ Hosp Toulouse, Dermatol Dept & Social Med, Ctr Sexually Transmitted Dis, Toulouse, France
[3] Univ Hosp Toulouse, Geriatr Dept, Toulouse, France
[4] Univ Inst Canc Toulouse Oncopole, Pathol Dept, Toulouse, France
[5] Univ Hosp Toulouse, Toulouse, France
[6] IUC, Dermatol Dept, Toulouse, France
[7] CHU Toulouse, Toulouse, France
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2021年 / 35卷 / 02期
关键词：
D O I：
10.1111/jdv.16850
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E120 / E121
页数：2
相关论文
共 50 条
  • [1] Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation
    Haroche, Julien
    Cohen-Aubart, Fleur
    Emile, Jean-Francois
    Arnaud, Laurent
    Maksud, Philippe
    Charlotte, Frederic
    Cluzel, Philippe
    Drier, Aurelie
    Hervier, Baptiste
    Benameur, Neila
    Besnard, Sophie
    Donadieu, Jean
    Amoura, Zahir
    BLOOD, 2013, 121 (09) : 1495 - 1500
  • [2] Major response to vemurafenib in patient with severe cutaneous Langerhans cell histiocytosis harboring BRAF V600E mutation
    Charles, Julie
    Beani, Jean-Claude
    Fiandrino, Giacomo
    Busser, Benoit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (03) : E97 - E99
  • [3] Prevalence of the BRAF V600E mutation in Greek adults with Langerhans cell histiocytosis
    Stathi, Dimitra
    Yavropoulou, Maria P.
    Allen, Carl E.
    Abhyankar, Harshal
    Scull, Brooks
    Tsoli, Marina
    Andreakos, Evangelos
    Kaltsas, Gregory
    Makras, Polyzois
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2022, 39 (06) : 540 - 548
  • [4] Clinicopathological Analysis of BRAF V600E Mutation in Pediatric Langerhans Cell Histiocytosis
    Wang, R.
    Sun, Y.
    Guan, W.
    Yu, W.
    Qiao, M.
    Wang, L.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S364 - S365
  • [5] Analysis of BRAF V600E Mutation in Japanese Patients with Langerhans Cell Histiocytosis
    Hayase, Tomomi
    Shioda, Yoko
    Imamura, Toshihiko
    Watanabe, Kenichiro
    Ohki, Kentaro
    Ohl, Yukiko
    Kawaharal, Yuta
    Morimotol, Akira
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S17 - S17
  • [6] Langerhans cell histiocytosis associated with classical Hodgkin lymphoma contains BRAF V600E mutation
    Zhang, Shanxiang
    Steinhilber, Julia
    Fend, Falko
    ANNALS OF HEMATOLOGY, 2019, 98 (01) : 231 - 233
  • [7] Langerhans cell histiocytosis associated with classical Hodgkin lymphoma contains BRAF V600E mutation
    Shanxiang Zhang
    Julia Steinhilber
    Falko Fend
    Annals of Hematology, 2019, 98 : 231 - 233
  • [8] HLX208, a novel BRAF V600E inhibitor, in adult patients with Langerhans cell histiocytosis and/or Erdheim-Chester disease harbouring BRAF V600E mutation
    Cao, X-X.
    Wu, Y.
    Liu, P.
    Ding, T.
    Ye, H.
    Cai, Z.
    Zhang, Y.
    Ma, J.
    Xu, Y.
    Fu, G.
    Hu, C.
    Hou, X.
    Wang, Q.
    Zhu, J.
    Li, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1599 - S1599
  • [9] BRAF V600E Immunohistochemistry in Cutaneous Langerhans Cell Histiocytosis
    Romano, R. C.
    Shon, W.
    Fritchie, K. L.
    LABORATORY INVESTIGATION, 2014, 94 : 142A - 142A
  • [10] BRAF V600E Immunohistochemistry in Cutaneous Langerhans Cell Histiocytosis
    Romano, R. C.
    Shon, W.
    Fritchie, K. L.
    MODERN PATHOLOGY, 2014, 27 : 142A - 142A
12345